Clinical Characteristics and Outcomes Among STEMI Patients with Cardiogenic Shock At Abu Dhabi City

Last updated: February 13, 2025
Sponsor: Abu Dhabi Health Services Company
Overall Status: Active - Recruiting

Phase

N/A

Condition

Heart Attack (Myocardial Infarction)

Heart Defect

Coronary Artery Disease

Treatment

N/A

Clinical Study ID

NCT06535503
SEHAResearch ID 747
  • Ages > 18
  • All Genders

Study Summary

A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age more than 18.

  • STEMI complicated by cardiogenic shock.

  • Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenicshock.

  • Patient admitted between January 2019 to March 2024.

Exclusion

Exclusion Criteria:

  • Age less than 18.

  • Shock patient not related to Myocardial infarction.

  • NSTEMI-related cardiogenic shock.

  • Patients who were not treated at SSMC or SKMC for the STEMI complicated bycardiogenic shock.

  • Patient not admitted between January 2019 to March 2024.

Study Design

Total Participants: 400
Study Start date:
July 01, 2024
Estimated Completion Date:
May 30, 2025

Study Description

Cardiovascular disease (CVD) accounts for 40% of mortality in the UAE, which is higher than the global average. Long-term trends, incidence studies, and best practice guidance on Cardiogenic Shock (CS) with ST-elevation Myocardial infarction (STEMI) in the United Arab Emirates (UAE) and the Gulf Cooperation Council (GCC) are limited.

Through this retrospective study, investigators aim to identify treatment modalities and trends, hospitalization events, and patient demographics and comorbidities which lead to participant recovery or mortality in Sheikh Khalifa Medical City (SKMC) and Sheikh Shakhbout Medical City (SSMC) tertiary hospitals for patients admitted with STEMI and CS or developed CS after hospitalization with STEMI during January 2020-January 2024.[200-400 participants]. Data will be collected from eligible patients' electronic medical records (EMR).

Connect with a study center

  • Sheikh Khalifa Medical City (SKMC)

    Abu Dhabi, 11001
    United Arab Emirates

    Active - Recruiting

  • Sheikh Shakhbout Medical City (SKMC)

    Abu Dhabi, 11001
    United Arab Emirates

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.